Hilary W Heuer1, Jacob B Mirsky, Erwin L Kong, Bradford C Dickerson, Bruce L Miller, Joel H Kramer, Adam L Boxer. 1. From the Memory and Aging Center (H.W.H., J.B.M., E.L.K., B.L.M., J.H.K., A.L.B.), Department of Neurology, University of California, San Francisco; and Frontotemporal Disorders Unit (B.C.D.), Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston.
Abstract
OBJECTIVE: The aims of this study were to examine executive dysfunction using an antisaccade (AS) task in normal elderly (NE) and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) as well as to evaluate the relationship between AS performance and cortical thinning within AD-associated regions. METHODS: We recorded eye movements in 182 subjects (NE: 118; MCI: 36; AD: 28) during an AS task. We also performed neuropsychological measures of executive function for comparison. Brain MRI scans were collected on most subjects, and cortical thickness was determined in 9 regions known to exhibit atrophy in AD dementia ("AD signature"). We investigated the relationships between AS and neuropsychological performance, as well as possible correlations between AS performance and cortical thickness. RESULTS: AS performance in MCI resembled that in NE; subjects with AD were impaired relative to both MCI and NE. In all subjects, AS performance correlated with neuropsychological measures of executive function, even after controlling for disease severity. In the subjects with MCI but not in NE, cortical thickness in frontoparietal AD signature regions correlated with AS performance. CONCLUSIONS: The AS task is a useful measure of executive function across the AD spectrum. In MCI, AS performance may reflect disease burden within cortical brain regions involved in oculomotor control; however, AS impairments in NE may have etiologies other than incipient AD.
OBJECTIVE: The aims of this study were to examine executive dysfunction using an antisaccade (AS) task in normal elderly (NE) and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) as well as to evaluate the relationship between AS performance and cortical thinning within AD-associated regions. METHODS: We recorded eye movements in 182 subjects (NE: 118; MCI: 36; AD: 28) during an AS task. We also performed neuropsychological measures of executive function for comparison. Brain MRI scans were collected on most subjects, and cortical thickness was determined in 9 regions known to exhibit atrophy in AD dementia ("AD signature"). We investigated the relationships between AS and neuropsychological performance, as well as possible correlations between AS performance and cortical thickness. RESULTS:AS performance in MCI resembled that in NE; subjects with AD were impaired relative to both MCI and NE. In all subjects, AS performance correlated with neuropsychological measures of executive function, even after controlling for disease severity. In the subjects with MCI but not in NE, cortical thickness in frontoparietal AD signature regions correlated with AS performance. CONCLUSIONS: The AS task is a useful measure of executive function across the AD spectrum. In MCI, AS performance may reflect disease burden within cortical brain regions involved in oculomotor control; however, AS impairments in NE may have etiologies other than incipient AD.
Authors: Douglas Galasko; David A Bennett; Mary Sano; Daniel Marson; Jeff Kaye; Steven D Edland Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller Journal: Cogn Behav Neurol Date: 2003-12 Impact factor: 1.600
Authors: Federica Agosta; Keith A Vossel; Bruce L Miller; Raffaella Migliaccio; Stephen J Bonasera; Massimo Filippi; Adam L Boxer; Anna Karydas; Katherine L Possin; Maria Luisa Gorno-Tempini Journal: Proc Natl Acad Sci U S A Date: 2009-01-22 Impact factor: 11.205
Authors: Joshua L Roffman; Adam Z Nitenson; Yigal Agam; Marlisa Isom; Jesse S Friedman; Kara A Dyckman; David G Brohawn; Jordan W Smoller; Donald C Goff; Dara S Manoach Journal: PLoS One Date: 2011-09-28 Impact factor: 3.240
Authors: Siobhan Garbutt; Alisa Matlin; Joanna Hellmuth; Ana K Schenk; Julene K Johnson; Howard Rosen; David Dean; Joel Kramer; John Neuhaus; Bruce L Miller; Stephen G Lisberger; Adam L Boxer Journal: Brain Date: 2008-03-24 Impact factor: 13.501
Authors: Uma Vaidyanathan; Stephen M Malone; Jennifer M Donnelly; Micah A Hammer; Michael B Miller; Matt McGue; William G Iacono Journal: Psychophysiology Date: 2014-12 Impact factor: 4.016
Authors: Kristin M Galetta; Kimberly R Chapman; Maritza D Essis; Michael L Alosco; Danielle Gillard; Eric Steinberg; Diane Dixon; Brett Martin; Christine E Chaisson; Neil W Kowall; Yorghos Tripodis; Laura J Balcer; Robert A Stern Journal: Alzheimer Dis Assoc Disord Date: 2017 Apr-Jun Impact factor: 2.703